← All companies

Astellas Pharma Inc.

4503 アステラス製薬株式会社
Annual Securities Report Consolidated Current period Pharmaceutical TSE Prime
Revenue
¥2.14tn+11.9% YoY
Operating income
¥382.6bn+832.4% YoY
Net income
¥291.5bn+474.5% YoY
Total assets
¥3.57tn
Compared with
Prior period
Fiscal year covered
2025-04-01 – 2026-03-31
EDINET document
S100YBPK
Not disclosed in this filing: ordinary_income. Shown as a gap rather than estimated.

Latest quarter

Q1 cumulative (3 months) · disclosed 5 August 2026 · Consolidated · cumulative from the start of the fiscal year
ItemCumulativeYoY Company forecast (FY)Progress
Revenue¥640.9bn+26.7%¥2.22tn29%
Operating income¥184.5bn+94.9%¥395.0bn47%
Net income¥141.8bn+107.3%¥300.0bn47%
Progress is the cumulative figure divided by the company's own full-year forecast. Japanese companies publish and revise that forecast every quarter — it is their number, not an analyst estimate.

All reported figures

As filed · extracted from XBRL · no editorial adjustment · hover a row for the XBRL element it came from
ItemJapanesePeriodValue
Revenue売上高Current period¥2.14tn
Revenue売上高Prior period¥1.91tn
Operating income営業利益Current period¥382.6bn
Operating income営業利益Prior period¥41.0bn
Net income attributable to owners of parent親会社株主に帰属する当期純利益Current period¥291.5bn
Net income attributable to owners of parent親会社株主に帰属する当期純利益Prior period¥50.7bn
Net cash from operating activities営業活動によるキャッシュ・フローCurrent period¥560.2bn
Net cash from operating activities営業活動によるキャッシュ・フローPrior period¥194.5bn
Total assets総資産Current period¥3.57tn
Total assets総資産Prior period¥3.34tn
Net assets純資産Current period¥1.83tn
Net assets純資産Prior period¥1.51tn
Cash and cash equivalents現金及び現金同等物Current period¥281.6bn
Cash and cash equivalents現金及び現金同等物Prior period¥188.4bn
Basic EPS1株当たり当期純利益Current period¥162.77
Basic EPS1株当たり当期純利益Prior period¥28.35
Equity ratio自己資本比率Current period51.3%
Equity ratio自己資本比率Prior period45.3%
Employees従業員数Current period14,099
Employees従業員数Prior period13,643
Revenue growth YoY売上高 前年比Current period11.9%
Operating income growth YoY営業利益 前年比Current period832.4%
Net income growth YoY純利益 前年比Current period474.5%
Operating margin営業利益率Current period17.9%
Net margin純利益率Current period13.6%

View the original filing on EDINET →